The "Bladder Cancer Diagnostics Market by Test Type, by Stages, by Cancer Type, by End User, and By Region" report has been ...

Climate change is increasing the risk of urological diseases, including cancer and kidney conditions, while urological ...

Two enzyme inhibitors join forces in reducing bladder cancer cell proliferation. n 1996, molecular biologist Kun Ping Lu, a ...

Cancer is a leading cause of mortality worldwide, and men above 40 are particularly at risk for certain types. While several ...

KRISTOPHER WENTZEL ONCOLOGY Hematologist Oncologist The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate Dr. Kristopher Wentzel leads the ...

The preeminent expert on the two-century history of what's now known as Albany Academies, McClintock spent decades ...

Jan. 30—"When the people lead, the leaders follow." That's the mantra being followed by environmental and community advocates who believe more action is needed to protect the public from a potentially ...

Sequential gemcitabine docetaxel is increasingly viewed as a valid option for BCG unresponsive non-muscle-invasive bladder cancer (NMIBC).

UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will particip ...

CARLSBAD, Calif. - Tyra Biosciences , Inc. (NASDAQ:TYRA), a biotech firm specializing in precision medicines targeting Fibroblast Growth Factor Receptor (FGFR) biology, today announced the appointment ...

ImmunityBio shares surged as much as 14% on Wednesday, reaching their highest level in nearly seven weeks while lifting ...